Nucleoside Hydrolase Inhibitors (LifePharms)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNucleoside Hydrolase Inhibitors (LifePharms)
Drug Alias NameN/A
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionHydrolases inhibitors
TargetsHydrolases
Therapy Area/IndicationsLeishmaniasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLifePharms Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLifePharms Inc
Active IndicationsN/A
Inactive IndicationsLeishmaniasis

Other Information

ATC CodeN/A
Related LinksN/A